BMT CTN Protocol 0102 -- A Trial of Tandem Autologous Stem Cell Transplants +/- Post Second Autologous Transplant Maintenance Therapy versus Single Autologous Stem Cell Transplant Followed by Matched Sibling Non-myeloablative Allogeneic Stem Cell Transplant for Patients with Multiple Myeloma

Below are protocol-related doucments, which may be periodically updated.

• Protocol synopsis, Version 7.0 dated May 15, 2006
• Protocol, Version 7.0 dated May 15, 2006
• Protocol amendment (summary of changes from Version 5.0 to 7.0)
• Patient and Donor consent forms, Version 7.0 dated May 15, 2006
• Health Quality of Life (HQL)
• FACT in English, version 1.1, 12-03
• FACT in Spanish, version 1.1, 12-03
• SF-36 Health Survey in English, version 2.0
• SF-36 Health Survey in Spanish, version 2.0
• Participating Centers
• Educational Materials
• Participant Brochure
• Informational Flyer
• Key Personnel

  Protocol Co-Chair: David Maloney, MD (206-667-5616) dmaloney@fhcrc.org

  Protocol Co-Chair:  Amrita Krishnan, MD (626-256-4673) akrishnan@coh.org

  Protocol Officer:  Marcelo Pasquini, MD (414-805-0700) mpasquin@hpi.mcw.edu

  Protocol Coordinator:  Kristin McCants (301-251-1161) kmccants@emmes.com

  Medical Monitor: Marcelo Pasquini, MD (414-805-0700) mpasquin@mcw.edu

 

This study reached the target accrual and closed to patient accrual on March 30, 2007.